Semaglutide provides multifaceted kidney protection and improves structural markers in patients with T2D and chronic kidney disease.

Elevated menopause proteomic scores are associated with poorer cognitive outcomes and increased risk for Alzheimer disease and dementia.

Dual-hormone fully closed-loop therapy increases time in glycemic range compared with multiple daily insulin injections (MDI), but not compared with hybrid closed-loop (HCL) therapy in adults with ...

Retatrutide therapy significantly decreases body weight and improves knee osteoarthritis pain and events in OSA in adults with obesity.

Sustained smoking cessation for at least 8 years significantly reduces risk for microvascular complications in patients with type 2 diabetes.

GLP-1 RAs and SGLT-2 inhibitors reduce risk for renal deterioration in patients with type 2 diabetes (T2D) and albuminuria.

Off-label testosterone prescriptions for women have surged; most are not for the approved indication of hypoactive sexual ...

High-dose oral menopausal hormone therapy increases risk for venous thromboembolism, ischemic stroke, and myocardial infarction.

Postoperative benefits include lower odds of major adverse cardiovascular events or infections. HealthDay News — Perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated ...

Insulin resistance may partially explain the increased long-term cardiovascular risk. HealthDay News — Premature menopause is associated with higher insulin levels and a greater risk for ...